Navigation Links
Amgen Appoints Robert A. Bradway to the Company's Board of Directors
Date:10/13/2011

THOUSAND OAKS, Calif., Oct. 13, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that its Board of Directors has appointed Robert A. Bradway to the Company's Board.  Bradway, 48, is Amgen's president and chief operating officer.  The addition of Bradway brings the number of Amgen board members to 13.

Bradway joined Amgen in 2006 as vice president, Operations Strategy and served as executive vice president and chief financial officer from April 2007 to May 2010.  Prior to joining Amgen, he was a managing director at Morgan Stanley in London where he had responsibility for the firm's banking department and corporate finance activities in Europe.  Bradway previously held positions of increasing responsibility at Morgan Stanley since 1985 with a focus on healthcare.  Bradway currently serves on the Board of Directors of Norfolk Southern Corporation.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.  Follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks

Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Amgen Announces 2011 Fourth Quarter Dividend
2. Amgen to Present at the UBS Global Life Sciences Conference
3. Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits
4. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign
5. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign
6. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research Meeting
7. Amgen Submits Application to Expand Indication for XGEVA® (Denosumab) to Prevent or Delay Spread of Prostate Cancer to the Bone
8. Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy
9. Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
10. Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
11. Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal ... cosmetic surgery industry at two recent North American investor forums specializing in medical ... Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 in New York ...
(Date:1/10/2020)... ... 09, 2020 , ... A new report from Tufts ... qualification process, a critical element of clinical trial set up and execution. According ... qualification process creates delays in initiation in 7% of clinical trials for biopharma ...
(Date:1/7/2020)... ... 07, 2020 , ... Absolute Antibody Ltd. , an ... its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models. The ... which Absolute Antibody has engineered into mouse-anti-mouse recombinant versions to improve research results. ...
(Date:12/31/2019)... ... 2019 , ... Vici Health Sciences announces it ... Maryland. Emphasis will be in expanding capabilities in both oral and parenteral dosage ... well positioned to meet the growing demand for its pharmaceutical formulation and analytical ...
Breaking Biology Technology:
(Date:2/10/2020)... ... February 10, 2020 , ... A Worcester Polytechnic Institute ... new coronavirus (2019-nCoV), a major development that potentially holds the key to understanding ... viral genome of the Wuhan coronavirus made available on the National Center ...
(Date:2/6/2020)... ... February 06, 2020 , ... ... to unique lab-made bioresearch materials, today announced an agreement with The Good ... and seafood a reality. Under the partnership, terrestrial meat and aquatic cell lines ...
(Date:2/1/2020)... , ... February 01, 2020 , ... Liver cancer, called ... and about 700,000 die from the disease. HCC is the 5th most common cancer ... among all countries when it comes to incidence of HCC, while China has half ...
Breaking Biology News(10 mins):